TVTX - Travere Therapeutics, Inc.
28.63
-0.350 -1.222%
Share volume: 868,325
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$28.98
-0.35
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-01-2024 | 10-31-2024 | 02-21-2025 | 05-01-2025 | 08-06-2025 | 10-30-2025 | 02-19-2026 | |
| Cash flow financing | -525.000 K | 782.000 K | 46.000 K | 139.119 M | 3.718 M | 1.475 M | -65.339 M | 26.679 M | |
| Other financing cash flows | -525.000 K | -525.000 K | 46.000 K | 3.356 M | 3.718 M | -62.000 K | 3.565 M | 25.424 M | |
| Cash flow | -14.632 M | -10.851 M | 3.665 M | 23.090 M | 2.814 M | 11.308 M | 35.569 M | -17.482 M | |
| Net income | -136.061 M | -70.409 M | -54.811 M | -60.264 M | -41.226 M | -12.755 M | 25.706 M | 2.729 M | |
| Depreciation | 9.880 M | 10.345 M | 11.239 M | 12.091 M | 12.802 M | 14.016 M | 15.788 M | 18.137 M | |
| Changes in inventories | 1.824 M | 0.000 | 0.000 | 0.000 | -3.664 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 104.898 M | 28.610 M | 46.126 M | -80.309 M | 41.290 M | 4.850 M | 86.591 M | -104.839 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | -40.000 K | -83.000 K | 146.000 K | 3.000 K | -470.000 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 82.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 140.000 K | 0.000 | |
| Cash Change | -14.925 M | -10.960 M | 4.118 M | 23.039 M | 3.362 M | 13.257 M | 35.776 M | -17.895 M |